Clinical Trial Update: Phase III Trial of Concurrent Chemotherapy Alone in Patients With Low-risk Nasopharyngeal Carcinoma [Phase 3]

View source ↗

Summary

A Phase III clinical trial evaluating concurrent chemotherapy alone in low-risk nasopharyngeal carcinoma is currently recruiting, sponsored by Sun Yat-sen Unive…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Nasopharyngeal Carcinoma

Snippet

Sponsor: Sun Yat-sen University | Conditions: Nasopharyngeal Carcinoma | Phase 3 | Status: RECRUITING